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Capicua (Cic) is a transcriptional repressor mutated in the brain cancer oligodendroglioma.
Despite its cancer link, little is known of Cic’s function in the brain. We show that nuclear Cic
expression is strongest in astrocytes and neurons but weaker in stem cells and oligoden-
droglial lineage cells. Using a new conditional Cic knockout mouse, we demonstrate that
forebrain-speciﬁc Cic deletion increases proliferation and self-renewal of neural stem cells.
Furthermore, Cic loss biases neural stem cells toward glial lineage selection, expanding the
pool of oligodendrocyte precursor cells (OPCs). These proliferation and lineage effects are
dependent on de-repression of Ets transcription factors. In patient-derived oligodendroglioma
cells, CIC re-expression or ETV5 blockade decreases lineage bias, proliferation, self-renewal,
and tumorigenicity. Our results identify Cic as an important regulator of cell fate in neuro-
development and oligodendroglioma, and suggest that its loss contributes to oligoden-
droglioma by promoting proliferation and an OPC-like identity via Ets overactivity.
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The identiﬁcation of cancer genes often presents opportu-nities to uncover previously unappreciated mechanismsregulating development. The transcriptional repressor
Capicua (CIC) has been identiﬁed as a likely tumor suppressor, as
CIC mutations and/or reduced expression are found in several
cancers. In the brain, CIC mutations are nearly exclusively found
in oligodendrogliomas (ODGs)—tumors composed of cells
resembling oligodendrocyte precursor cells1,2. Indeed, concurrent
IDH1/2 mutation, single-copy losses of 1p and 19q, and mutation
of the remaining copy of CIC on chr 19q13 are together highly
characteristic of ODG3–5. These associations suggest a unique
relationship between CIC and glial biology.
Prior work has shown that Cic is a transcriptional repressor
downstream of receptor tyrosine kinase (RTK) signaling6. Bind-
ing of Cic to the sequence T(G/C)AATG(G/A)A in enhancers
and promoters leads to transcriptional repression of its target
genes7,8. This default repression is relieved upon RTK
signaling6,9–11, permitting transcription of targets—among which
are PEA3/ETS transcription factors ETV1/4/512. To date, knowl-
edge of Cic’s function in mammalian development or in the brain
is limited. Yang et al. using Cic conditional knockout mice,
reported that Cic loss increases a population of proliferating
Olig2+ cells in the brain, and potentiates tumorigenesis in a
PDGFR-driven glioma model13. The mechanisms underlying
those ﬁndings, however, remained undeﬁned. Meanwhile, in the
non-neoplastic context, Lu et al.14 showed that impairing the
interaction of Cic with Ataxin1 results in neurobehavioral and
neurocognitive phenotypes, and alteration in cortical neuronal
populations—indicating a role for Cic in neuronal biology as well.
Deciphering the molecular mechanisms of Cic function may shed
light on these varied phenotypes.
Here, we examine Cic expression in the mammalian forebrain,
and take a loss-of-function approach to determine its role in
specifying neuronal-glial identity. Our results reveal an important
role for Cic in regulating the proliferation and lineage speciﬁca-
tion of neural stem cells—with loss favoring neural stem cell
(NSC) proliferation and glial production at the expense of neu-
ronal production. Furthermore, we show that these effects are
mediated largely through Cic’s regulation of Ets factors. The
proliferative dysregulation is recapitulated in ODG cells, where
CIC re-expression or Ets blockade reduces tumorigenicity. Our
ﬁndings reveal an important role for CIC in development and
ODG, and identify Etv5 as a potential therapeutic target for ODG.
Results
Nuclear Cic levels are cell type- and stage-speciﬁc. To investi-
gate Cic’s potential function in forebrain development and ODG,
we ﬁrst examined its expression in several regions and cell types
in the mouse brain. Immunoﬂuorescence staining revealed that
all cell types examined have some detectable level of Cic, whether
cytoplasmic or nuclear. Because of its previously identiﬁed role as
a transcriptional repressor, however, we quantitated nuclear Cic
staining intensity across cell types and stages.
Focusing ﬁrst on the NSC compartment, we assessed tissue
from the dorsal telencephalon at embryonic day (E) E12. At this
stage, non-lineage restricted NSCs are found in the ventricular
zone (VZ) where they can be identiﬁed by their location and
expression of the transcription factor Sox215. Consistent with the
previous demonstration that RTK signaling is locally elevated in
the embryonic VZ16,17 and that Cic nuclear export is regulated by
ERK-mediated Cic phosphorylation6,9–11, Sox2+VZ cells
showed Cic localization that was predominantly cytoplasmic,
with weaker nuclear expression (Fig. 1a). Pools of stem/
progenitor cells are not limited to development, but also persist
postnatally in the subventricular zone (SVZ) of the lateral
ventricle and in the subgranular layer (SGL) of the hippocampal
dentate gyrus18,19. In the SVZ and SGL of postnatal day (P) P21
and P56 mice, nuclear Cic was also weak in Sox2+ cells—in
contrast to stronger nuclear expression in adjacent differentiated
cells (Fig. 1b, c). Thus, in embryonic and postnatal brain, NSCs
have low levels of nuclear Cic.
As cells differentiated, Cic nuclear localization increased, but
with notable differences between cell types. In P56 cortex,
NeuN+ neurons showed the strongest nuclear Cic (Fig. 1i, j).
The increase in Cic within the neuronal lineage was detectable
during embryonic neurogenesis, with a modest increase detected
as cells transitioned from Sox2+ stem cells to Tbr2+ neuronal
intermediate progenitors, and then a more-marked elevation in
Tbr1+ post-mitotic neurons in the intermediate zone and
cortical plate, where nuclear Cic levels approached those of
adult cortical neurons (Fig. 1g–j). Nuclear Cic was also increased
in GFAP+ or Aldh1+ astrocytes in the cortex and white
matter relative to Sox2+ cells (Fig. 1d; Supplementary Fig. 1a).
The lowest levels of nuclear Cic were found in the oligoden-
droglial lineage. Olig2 is a bHLH transcription factor that
is expressed in cells at or before oligodendrocyte speciﬁcation
and continues to be present throughout oligodendroglial
differentiation20,21. Olig2+ Pdgfra+OPCs had the lowest levels
of all, with a modest increase in CNPase+ immature oligoden-
drocytes, and a further increase in mature CC1+ oligodendro-
cytes (Fig. 1e, f, j; Supplementary Fig. 1b). Overall, the mean
nuclear signal intensity for Cic was signiﬁcantly lower in Sox2+
and Pdgfra+ cells than in NeuN+ cells, Tbr1+ cells, or Gfap+
cells (Fig. 1j). As both NSCs and OPCs are proliferation-
competent cell types, this pattern of expression raised the
possibility that CIC may repress proliferation-related genes
and/or early oligodendroglial-promoting programs.
Cic loss increases glial cells at the expense of neurons. Domains
in Cic include an HMG box and a C-terminal C1 domain that
together mediate DNA binding, and a C-terminal Gro-L domain
that mediates protein–protein interactions10,22–25. We generated
Cic conditional knockout mice in which exons 2–11 of Cic were
ﬂanked by loxP sites, with the ﬂoxed region containing all exons
encoding the HMG box. Upon Cre expression, exons 2–11 are
excised and the remaining exons 12–20 are frameshifted (Fig. 2a),
ablating all of these critical domains. We used these animals for
in vivo studies and for cell line generation to dissect Cic’s
functions.
We crossed Cic-ﬂoxed mice to Foxg1-Cre mice26, to generate
forebrain-speciﬁc Cic deletion starting at E10.5 (Fig. 2a, b).
CicFl/Fl;FoxG1Cre/+ animals were born in approximate Mendelian
ratios and were grossly normal at birth, but became visible runts
by P7, and were lethal by P22. The reason for lethality is unclear,
but we suspect that poor feeding secondary to impaired
neurologic function may be related to their decline. Although
all major forebrain structures (e.g., cortex, white matter, deep
nuclei, hippocampi) were present, and the cortex was laminated;
Cic-null cerebra were smaller than those of littermate controls
(Fig. 2c). The smaller cerebral size was due to global decreases
in gray matter and white matter (Supplementary Fig. 2a–c).
Despite decreased thickness/size of corpus callosum and cortex,
however, the tissue showed increased cellularity (Supplementary
Fig. 2b–d). As neuronal density was not signiﬁcantly different
in the knockouts, (Supplementary Fig. 2e), the ﬁndings suggested
a decrease in total neurons and an increase in glia.
Evaluation of P21 cortices conﬁrmed shifted cell proportions
in Cic-null brains. NeuN+ cells were decreased in Cic-null
cortices compared with Cic-wildtype or heterozygote control
cortices (Fig. 2d, e). In contrast, Gfap+ cells were increased in
knockouts relative to controls (Fig. 2d, e). Olig2+ cells were also
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signiﬁcantly increased (Fig. 2f, g)—a ﬁnding corroborated by
increased Sox10+ (Fig. 2d, e). In oligodendroglial lineage
progression, earlier stages were particularly increased, whereas
later stages were decreased in Cic-null animals. Olig2+ Sox2+
cells and Olig2+ Pdgfra+OPCs were increased (Fig. 2f, g and
Supplementary Fig. 3), whereas CNPase+ immature oligoden-
drocytes were decreased (Fig. 2f, g) in Cic-null animals. Mbp,
the product of mature oligodendrocytes, was also decreased in
Cic-null brains (Fig. 2f, g).
We found no change in apoptosis in the knockout brains
(Supplementary Fig. 4f), suggesting that the phenotype of altered
cell proportions was not due to increased cell death. Other
possibilities were that Cic loss could be affecting NSC lineage
selection, or that Cic loss could have speciﬁc effects on OPCs.
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In the following work, we focus our investigations on Cic’s role
at the NSC stage, and examine its role in proliferation and
lineage selection.
Cic deﬁciency increases NSC proliferation and self-renewal. To
determine whether Cic loss affects NSC proliferation, we elec-
troporated pCIG2-Cre (or pCIG2 empty control) into E13 CicFl/Fl
embryos and performed EdU labeling in the last 30 min prior
to sacriﬁce. Forty-eight hours post electroporation, the fraction
of GFP+ cells that was EdU+was markedly increased in cre- vs.
control-electroporated brains (Fig. 3a, b). These ﬁndings sup-
ported a cell-autonomous increase in NSC proliferation with CIC
loss. There was also an increase in EdU+ cells among non-GFP
cells in the electroporated areas, suggesting additional non-cell-
autonomous effects that we did not pursue (Supplementary
Fig. 6e). To conﬁrm the cell-autonomous gains in NSC pro-
liferation, we turned to cell culture. Cic-null and control NSCs
were derived from E15 Cic-ﬂoxed cells transfected ex vivo with
Cre or control plasmids (Fig. 3c). 3 days after plating equal cell
numbers in NSC proliferation media, however, we found a
threefold increase in numbers of Cic-null cells relative to controls
(Fig. 3d). These data were corroborated by Alamar blue assay
(Supplementary Fig. 4a), Ki67 immunostaining (Fig. 3e) and cell
cycle analysis (Fig. 3f), which showed increased viability and
cycling in Cic-null cells. There were no differences in the num-
bers of dead cells between the two (Supplementary Fig. 4c).
Together, the data show that Cic is a strong negative regulator
of proliferation in forebrain NSCs.
Self-renewal of Cic-null cells was also assessed by clonogenic
assay (Fig. 3g). In this assay, after plating equal numbers of
dissociated cells in semi-solid media, a higher number of spheres
indicates higher number of self-renewing cells in the initial
population, whereas sphere volume is a more general indicator of
proliferation that includes effects from cell cycle kinetics, modes
Fig. 1 Differential Cic expression among cell types in the developing and mature brain. a–h Representative images of immunoﬂuorescence staining for
Cic expression in a Sox2+ stem cell populations in E12 subventricular zone, b P21 subventricular zone, and c P56 hippocampal dentate gyrus subgranular
zone. Cic expression in glial cells in the adult brain showing localization in d Gfap+ cortical astrocytes, e Pdgfra+white matter OPCs, and f CNPase+
mature oligodendrocytes. Cic expression in neuronal populations in g E15 Tbr2+ early-born neurons in the SVZ and IZ, h E15 Tbr1+ late-born neurons
in the cortical plate, and i adult post-mitotic NeuN+ cortical neurons. j Quantitation of Cic nuclear staining intensities, plotted by brain cell types.
All quantitation performed on P56 brain except Tbr2 and Tbr1, which were analyzed at E15. Each point represents one cell quantitated. Results from a
minimum of 24 cells per marker from the boxed regions used for image analysis; data are from n= 5 brains. Pairwise comparisons between cell types
performed by ANOVA with Tukey’s post hoc test. Source data are provided as a Source Data ﬁle. Scale bar: 50 μm. Data shown as mean ± SD. *p < 0.05,
**p < 0.01, ****p < 0.0001. Labels: LV–lateral ventricle, GCL–granule cell layer, SGZ–subgranular zone, SVZ–subventricular zone, Ctx–cortex
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Fig. 2 Forebrain-speciﬁc Cic deletion increases glial cells at the expense of neurons. a Targeting strategy for Cic conditional knockout mice. Exon numbering
is shown relative to Cic transcript variant 1. b Forebrain-deletion of Cic starting from E10.5 by crossing CIC-ﬂoxed line with FoxG1-cre. CicFl/Fl;FoxG1Cre/+
animals are compared with CicFl/+;FoxGCre/+ or CicFl/Fl;FoxG1+/+ as controls. c Representative gross morphology of Cic-deleted and Cic-wildtype brains at
P21. d, e Representative staining d and total quantitation e of NeuN+ , Gfap+ , and Sox10+ cells in Cic-deleted (CicFl/Fl;FoxG1Cre/+) cortex vs control
(CicFl/Fl;FoxG1+/+). Scale bar: 50 μm. f, g Representative staining f and total quantitation g of Olig2+ , Pdgfra+ , and CNPase+ cells in lateral corpus
callosum, and Mbp expression in lateral corpus callosum at P2. Data from n= 5 mice per each group with the exception of Pdgfra staining (n= 3 control,
n= 4 Cic-null) and Mbp staining (n= 6). Statistical analyses performed by unpaired t test. Scale bar: 50 μm. Source data are provided as a Source Data ﬁle.
Data shown as mean ± SD. *p < 0.05, **p < 0.01, ****p < 0.0001. Labels: Ctx–cortex, CC–corpus callosum
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of cell division, and the fraction of cells remaining in or exiting
the cell cycle. Both Cic-null and control NSCs generated spheres,
but Cic-null NSCs generated more spheres (Fig. 3g, h) and larger
spheres (Fig. 3g, i) compared with controls. Thus, Cic loss confers
not only higher proliferation but higher self-renewal in NSCs, at
least when cells are in conditions promoting NSC proliferation.
Cic regulates NSC cell division asymmetry. During neurodeve-
lopment, the NSC pool is ﬁrst expanded by symmetric pro-
liferative divisions, followed by rounds of asymmetric divisions of
stem and progenitor cells generating neurons and glia, and ﬁnally
by terminal symmetric differentiative divisions18. The balance
between symmetric and asymmetric divisions is important;
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deﬁciency in asymmetric divisions and an increase in symmetric
divisions can lead to neoplasia27.
To investigate whether alteration of cell division mode was
a feature of the Cic-deﬁcient NSCs, we performed paired cell
assays. Cic-null and -control NSCs were seeded at low density
in adherent cultures for 24 h, then ﬁxed and stained for Ki67
(Fig. 3j). Pairs where both daughter cells were Ki67+were scored
as symmetric proliferative. Pairs where daughter cells differed in
Ki67 (i.e., Ki67+/Ki67−) were scored as asymmetric. Pairs where
both daughter cells were Ki67− were scored as symmetric
terminal. Cic-null cells underwent more frequent symmetric
proliferative divisions and fewer asymmetric divisions compared
with controls (Fig. 3k). Although not signiﬁcant, there was a
trend to decreased symmetric terminal divisions between Cic-null
and control cells (Fig. 3k). The net effect of these alterations in
cell division symmetry/asymmetry is the presence of more cycling
and self-renewing cells.
Consistent with the above increased NSC proliferation and self-
renewal observed in vitro, examination of our electroporated
brains showed that the fraction of GFP+ cells that were Sox2+
was higher in cre- versus control-electroporated brains (Fig. 4a–c).
There was no change in activated Caspase-3 (Supplementary
Fig. 4d, e), indicating that the increased Sox2+ fraction in vivo
was not owing to increased apoptosis of other cells. Cumulatively,
the ﬁndings of increased NSC proliferation, decreased asym-
metric divisions, and increased Sox2+ cells suggested that Cic
deﬁciency increases a population of self-renewing (albeit
dysregulated) stem-like cells.
Gliogenic determinants are elevated in Cic-deﬁcient NSCs.
Although the proliferative effects of Cic deﬁciency in NSCs were
clear, what was intriguing was the added possibility that Cic loss
may be affecting lineage selection. As the CicFl/Fl;FoxG1Cre/+
phenotype was characterized by fewer neurons and increased
glia, we asked whether Cic loss altered the expression of glial
lineage selection factors and, thus, gliogenic potential.
To this end, we examined Sox9 and Olig2 expression in
the NSCs and their progeny after E13 Cre- or control-
electroporation. Sox9 is an HMG box transcription factor present
in a range of central nervous system cells, including stem cells,
glial precursors, and later glia. It has key roles in stem cell
maintenance and in driving differentiation programs away from
neurogenesis, toward gliogenesis, at the stage of gliogenic
initiation28–30. Similarly, Olig2 is expressed in many cells
including stem cells, oligodendroglial lineage cells, and some
neurons; but it has a major role in establishing oligodendroglial
competence. Two days post electroporation, the fraction of
GFP+ cells expressing Sox9 was signiﬁcantly increased over
controls (Fig. 4d, e). Five days post electroporation, a smaller
fraction of Cic-deleted NSCs became Tbr1+ early-born (Fig. 4f, g).
Conversely, greater fractions became Aldh1+ astrocytes and
Pdgfra+OPCs (Fig. 4h–l).
These ﬁndings were echoed in the expression of stem and
lineage markers in cultured NSCs. When maintained in serum-
free NSC proliferation media, both Cic-null and control NSCs
strongly expressed Nestin, as expected, and were devoid of
staining for Gfap, bIII-Tubulin (as detected by Tuj1), and
committed oligodendroglial markers (Fig. 5a–c; Supplementary
Fig. 3c). There, was, however, a marked increase in the percentage
of cells expressing Sox9 and Olig2 in Cic-null cultures (Fig. 5a–c).
It is reasonable to posit that the increased Sox9 and Olig2 present
in Cic-null NSCs then sets an intrinsic foundation for pro-glial
P
C
IG
2-
C
re
E
m
pt
y
Tbr1/GFP/DAPISox9/GFP/DAPISox2/GFP/DAPI Aldh1/GFP/DAPI Pdgfrα/Olig2/GFP/DAPI
Ctx
Ctx
P
C
IG
2-
C
re
P
C
IG
2-
C
re
 +
 P
B
-D
N
E
tv
5
P
C
IG
2-
C
re
 +
 P
B
-D
N
E
tv
5
E
m
pt
y
E
13
   
   
   
  1
5 
el
ec
tr
op
or
at
io
n
LV
VZ
VZ
Ctx
LV
VZ
LV
LV
LV
CC
CC
CC
LV
LV
LV
Ctx
Ctx
Ctx
Ctx
Ctx
Ctx
Constructs
da f h jb
c e i k lg
E
13
   
   
   
  1
8 
el
ec
tr
op
or
at
io
n
+
–
15 20
15
10
5
0
6
4
2
0
6 ns
4
2
0
10
5
0
15 20
15
10
5
0
10
5
0
* * * **
***
**
*
*
** *
*
Cre –
–
+
–
+
+DN-Etv5
Cre –
–
+
–
+
+DN-Etv5
Cre –
–
+
–
+
+DN-Etv5
Cre –
–
+
–
+
+DN-Etv5
Cre –
–
+
–
+
+DN-Etv5
Cre –
–
+
–
+
+DN-Etv5
S
ox
2+
G
F
P
+
 (
%
)
G
F
P
+
S
ox
9+
G
F
P
+
 (
%
)
G
F
P
+
T
br
1+
G
F
P
+
 (
%
)
G
F
P
+
A
ld
h1
+
G
F
P
+
 (
%
)
G
F
P
+
O
lig
2+
G
F
P
+
 (
%
)
G
F
P
+
P
dg
fr
a+
O
lig
2+
G
F
P
+
O
lig
2+
G
F
P
+
(%
)
Fig. 4 Deletion of Cic in the neurogenic period biases NSCs to glial lineage selection. a Localized deletion of Cic in neural stem cells via in utero
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Tbr1+ neurons f, g, Aldh1+ astrocytes h, i, Olig2+ oligodendrogial lineage cells j, k, and Pdgfra+ oligodendrocyte precursors cells l detected 5 days after
E13 electroporation, analysis at E18. Data from n= 5 for control and n= 6 mice for Cre for Tbr2 staining; n= 6 for control and n= 5 for cre for
Aldh1 staining; and n= 4 per group for Olig2 and Pdgfra staining. Statistical analyses between control and experimental groups performed by ANOVA with
Tukey’s post hoc test. Scale bars: 50 μm. Source data are provided as a Source Data ﬁle. Data shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001,
ns–not signiﬁcant. Labels: Ctx–cortex, LV–lateral ventricle, VZ–ventricular zone
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or pro-oligodendroglial programs starting early in the neural
cellular hierarchy.
Cic-deﬁcient NSCs are biased to the oligodendroglial lineage.
To directly test cell type speciﬁcation capacity, we challenged
Cic-null and control NSCs with exposure to different lineage-
promoting culture conditions. Neuronal differentiation was
induced by culturing cells with B27 and cAMP. Astrocytic dif-
ferentiation was induced by culturing NSCs in 1% FBS and N2.
Oligodendroglial differentiation was induced by culturing cells
in media with B27 and tri-iodo-thyronine. After 10-day exposures
to these conditions, cultures were analyzed for cellular identity
and morphology.
Following exposure to neuronal-promoting conditions, Tuj1+
cells comprised the majority of cells in Cic-wildtype cultures,
but were only a minority in Cic-null cultures (Fig. 5d, g).
Furthermore, the Tuj1+ Cic-null cells that were present had fewer
and less complex cell processes than in their control counterparts
(Fig. 5d). Likewise, in response to astrocyte-promoting conditions,
Gfap+ cells comprised the majority of cells in control cultures, but
only a minority in Cic-null cultures (Fig. 5e, h); and the Gfap+Cic-
null cells that were present displayed more rudimentary processes
than controls (Fig. 5e, h). In the oligodendrocyte-promoting
condition, there was a higher fraction of Olig2+ cells in Cic-null
cultures compared with control, as well as increased Olig2 by
western blotting (Fig. 5f–j). When analyzed for markers of OPCs
versus more mature oligodendrocytes, Cic-null cultures also had a
greater percentage of Olig2+ Pdgfra+ cells than Cic-wildtype
cultures (Fig. 5f–j). Conversely, the percentage of Olig2+MBP+
cells was decreased in Cic-null cultures (Fig. 5f–j). Furthermore, in
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the few Olig2+MBP+ cells that were present in Cic-null cultures,
process formation was rudimentary compared with Cic-wildtype
cells (Fig. 5f). Thus, Cic is required for appropriate NSC
responsiveness to extrinsic speciﬁcation/differentiation cues. Our
ﬁndings indicate that Cic-deﬁcient NSCs have more limited ability
to specify neuronal or astrocytic fates, but have increased
permissiveness to the oligodendroglial lineage. Some ﬁndings
suggest an additional maturation defect after lineage commitment,
but we did not address this here.
We then asked what Cic-null NSCs became in the astrocytic
and neuronal conditions, if not astrocytes and neurons. In the
astrocyte-promoting condition, the Gfap- population was com-
prised predominantly of Sox2+ cells and, to a lesser extent
Olig2+ cells, both of which were signiﬁcantly increased in Cic-
null cultures (Fig. 6a, b). Tuj1+ cells were rare in this condition,
and did not differ between Cic-null cells and controls. In the
neuronal-promoting condition, the Tuj1- population was simi-
larly comprised predominantly of Sox2+ cells and Olig2+ cells
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(Fig. 6c, d), with a small but non-signiﬁcant increase also in the
percentage of Gfap+ cells in the Cic-null cultures (Fig. 6d). With
respect to oligodendroglial-promoting conditions, Sox2+ cells
were increased, whereas both Tuj1+ and Gfap+ cells were
reduced compared with controls (Fig. 6e, f). These data further
support that Cic-deﬁcient NSCs are less responsive to neuronal
and astrocytic cues, and instead remain as stem cells or are
oligodendroglial-biased.
Because we previously found that Cic loss increases NSC
proliferation, it was important to exclude that the decreased
neuronal and astrocytic fractions observed in our experiments
were owing to a dilutional effect from greater NSC/OPC
proliferation. In both conditions, after the 10-day differentiation
protocol, only rare proliferating cells remained (Supplementary
Fig. 4j). Of the Sox2+ and Olig2+ cells present in the neuronal
or astrocytic conditions, < 1% were EdU+ , and there were no
signiﬁcant differences between the proliferation of Sox2+ or
Olig2+ cells in the Cic-null vs. control cultures (Fig. 6g, h).
Moreover, when the data were analyzed for absolute numbers of
cells rather than percentages of cells, we found fewer total Gfap+
cells in the astrocytic conditions, and a fewer total Tuj1+ cells in
the neuronal conditions in Cic-null cultures compared with
controls (Fig. 6i, j). No differences in apoptosis were found
between Cic-null and control cultures (Supplementary Fig. 4j).
Together, these data indicate that the cell type skewing is not a
result of increased NSC proliferation, but rather is owing to
intrinsic fate bias.
Cumulatively, we conclude that Cic is a critical regulator of
proliferation, self-renewal, and cell fate of NSCs. Loss of Cic
expands the OPC pool by not only by increasing NSC proliferation
but also by biasing their speciﬁcation towards oligodendrocytes.
Cic represses Ets factor expression in the forebrain. As Cic is a
transcriptional repressor, one mechanism for our ﬁndings is that
Cic loss de-represses speciﬁc genes driving NSC proliferation
and lineage selection. In this respect, Etv genes, encoding Ets-
domain transcription factors, are candidate targets-of-interest.
Etv1,4,5 have been identiﬁed as Cic targets in various mammalian
cells12,31, and are overexpressed in ODGs (Supplementary
Fig. 5f–h and32). Furthermore, previous studies have documented
Cic occupancy at the Etv5 promoter, at least in cerebellar tissue33.
Consistent with a functional relationship between Cic and Ets
expression in the forebrain, we found that NSCs and OPCs
(the cells with the lowest levels of nuclear Cic), expressed the
highest levels of Etv4 and 5 (Fig. 7f–k; Supplemental Fig. 5e).
We also conﬁrmed that in forebrain tissue, there is evidence of
Etv5 promoter occupancy by Cic (Fig. 7c).
If Ets factors are the mediators of the observed effects of Cic
loss, we would expect their levels to be elevated in our
experimental systems of Cic loss. Indeed, after 2 days of growth
in oligodendroglial conditions, Etv5 mRNA was increased ~ 37-
fold, whereas Etv4 transcripts were increased ~ 19-fold in Cic-null
cells (Fig. 7a)—a ﬁnding also conﬁrmed at the protein level
(Fig. 7b). Etv1 levels, however were much lower, and did not
signiﬁcantly differ between Cic-null and -wildtype cells. Although
both Etv4 and Etv5 were both de-repressed in the absence of Cic,
because of the comparatively higher levels of Etv5 relative to
Etv4, as well as previous studies implicating Etv5 in mediating
glial fate decisions34, we focused additional studies on this Ets
factor. Electroporation of Cic shRNA into the telencephalic
VZ resulted in upregulation of Etv5 transcript in the electro-
porated patch within 48 h (Fig. 7d). Our Cic-ﬂoxed, Cre-
electroporated brains also showed an increase in Etv5 protein
in the electroporated patch (Fig. 7e). These data support that the
PEA3 Ets transcription factors, particularly Etv4 and Etv5, are
transcriptional repressive targets of Cic in the forebrain.
Etv5 de-repression mediates effects of Cic loss in NSCs. To
determine whether the proliferative increase and OPC bias that
we observed with CIC ablation was mediated by Etv5, we ﬁrst
asked whether Etv5 overexpression alone was sufﬁcient to mimic
the phenotype of Cic deﬁciency. Electroporation of wildtype Etv5
phenocopied the increased proliferation of CIC-null cells (Fig. 8g,
h; Supplementary Figs. 5i, 6a). Similarly, Etv5 overexpression
acutely increased proliferation of cultured NSCs (Fig. 8k, Sup-
plementary Fig. 6c). We also performed epistasis experiments
introducing a dominant negative form (DNETV5) in which Etv5
was fused to the Engrailed transcriptional repressor domain.
Introduction of DNETV5 or knockdown of Etv5 with siRNA or
shRNA reduced the proliferation of cultured Cic-deﬁcient NSCs
back to control levels (Fig. 8l; Supplementary Fig. 6d). In vivo,
the increased proliferation observed upon deletion of Cic by cre
electroporation was abrogated by co-electroporation with
DNETV5, resulting in proliferation that was comparable to
baseline (Fig. 8i, j compared with 8g, h; Supplementary Fig. 6b).
Based on the extent of the effects of Etv5 overexpression and
DNETV5 rescue in these assays, we conclude that the proliferative
effects of Cic loss are largely driven by de-repression of Etv5.
With respect to the altered proportions of cell types that we
had observed in Cic-deﬁcient NSCs exposed to the different
lineage-speciﬁc culture conditions, overexpression of wildtype
Etv5 also phenocopied Cic loss in many respects. There were
decreased fractions of Tuj1+ cells and Gfap+ cells in the
neuronal and astrocytic conditions, and increased fractions of
Olig2+ and Olig2+ Pdgfra+ cells in the oligodendrocytic con-
dition when Etv5 was overexpressed—although the severity of the
changes was somewhat less marked with Etv5 overexpression
compared with Cic loss. DNETV5 was also able to substantially
(although incompletely) rescue the phenotype of Cic-deﬁcient
cells in these assays. In the neuronal and astrocytic conditions,
DNETV5 signiﬁcantly increased the populations of Tuj1+ and
Gfap+ cells, respectively (Fig. 8a, b, d, e). The shifts in Olig2+
cells and Olig2+ Pdgfra+OPCs also returned to control levels
(Fig. 8c, f). The MBP+ fraction similarly showed a substantial
although partial rescue (Fig. 8c, f). That the DNETV5 rescue in
several of the differentiation assays was signiﬁcant but only
partial suggests that other factors may contribute to the lineage
speciﬁcation effects. Nevertheless, the results point to Etv5 as
playing a large part in the lineage-biased phenotype.
Thus, Etv5 overexpression is both sufﬁcient for inducing
proliferation and cell fate bias effects, and is necessary for the
proliferative dysregulation and lineage bias resulting from
CIC loss.
Etv5 blockade decreases tumorigenicity of human ODG. The
above studies provide a plausible framework for understanding
how disruption of Cic, a cancer-associated gene, can perturb a
cell’s normal developmental trajectory. We then asked whether in
established ODG, persistent loss of CIC or the resulting ETV5
upregulation is required for maintaining malignancy. We used
two patient-derived ODG cell lines, BT54 and BT88, to investi-
gate this. Both lines harbor 1p19q co-deletion35. BT54 harbors a
splice acceptor site mutation in the remaining CIC exon 6,
whereas BT88 harbors a missense mutation in the remaining CIC
exon 203. In both BT54 and BT88, either stable re-expression of
wildtype CIC or stable expression of DNETV5 signiﬁcantly
reduced proliferation as measured by EdU incorporation (Fig. 9a,
c, f). Sphere-forming ability was also decreased by CIC expression
or by introduction of DNETV5 (Fig. 9b, d, e). These anti-
proliferative and anti-self-renewal effects were also seen using
ETV5 shRNA (Supplementary Fig. 7a, b). Consistent with an
ongoing requirement for CIC loss or ETV5 expression for
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proliferation and self-renewal in ODG, in vivo tumorigenicity of
BT88 cells was markedly reduced, and survival of animals was
increased, by stable expression of either wildtype CIC or DNETV5
(Fig. 10). Thus, in cells that are already transformed to ODG, CIC
loss and the subsequent elevation of ETV5 remains important to
sustain the proliferative phenotype.
CIC loss and ongoing ETV5 elevation are also required for
preventing oligodendroglial differentiation in established ODG.
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In response to oligodendrocyte differentiation conditions, ODG
cells with CIC re-expression or DNETV5 showed increased
expression of CNPase compared with controls, indicating improve-
ment in capacity for the tumor cells to differentiate and mature
along the oligodendroglial progression (Figure 9g, h; Supplemen-
tary Fig. 7c, d). Interestingly, however, effects on neuronal and
astrocytic differentiation were mixed. CIC re-expression increased
the ability of cells to respond to neuronal differentiation cues by
increasing expressing bIII-Tubulin (Tuj1+ ) and extending
neurites; however this was not phenocopied by DNETV5 (Fig. 9g,
h; Supplementary Fig. 7c, d). With respect to expression of GFAP
in response to astrocytic differentiation cues, no signiﬁcant
differences were detected with either CIC re-expression or DNETV5
introduction compared with BT88 control (Fig. 9g, h; Supplemen-
tary Fig. 7c, d). The results suggest that although CIC loss and
ETV5 overexpression maintain ODG cell proliferation and self-
renewal, and prevent progression of oligodendroglial differentiation
in established ODG; other aspects such as the capacity for neuronal
or astrocytic differentiation are determined by additional genetic
(or epigenetic) alterations, at least in our culture system. The effects
of CIC and ETV5 on ODG differentiation were not evaluated
in vivo, however, as the lesions resulting from implantation of CIC-
or DNETV5-expressing BT88 cells were too small to provide
meaningful cell numbers for assessment.
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differentiating condition, ODC c, f from n= 3 biological replicates, with three technical replicates each, for cell culture studies. g, h Representative images
and quantitation of EdU incorporation 2 days post electroporation of wildtype ETV5 or empty control plasmid, both carrying mCherry as a marker, into E13
CICFl/Fl VZ. Note: mCherry ﬂuorescence and EdU staining were false-colorized to green and red after grayscale imaging. Scale bar: 50 μm. Data from n= 4
mice per each group. Scale bar: 50 μm. i, j Representative images and quantitation of EdU incorporation 2 days post-electroporation of Cre only or of Cre
co-electroporated with DNETV5 into E13 CICFl/Fl VZ. Data from n= 4 mice per each group. Scale bar: 50 μm k EdU incorporation assay in cultured
Cic-wildtype NSCs without or with ETV5 overexpression from n≥ 3 biological replicates. l EdU incorporation in Cic-ﬂoxed NSCs with Cre, and without or
with DNETV5 expression from n≥ 3 biological replicates. Data shown as mean ± SD. Statistical analyses performed either t test in h, j, k, l; or with ANOVA
with Tukey’s post hoc test in d, e, f. ns–not signiﬁcant, *p < 0.05, **p < 0.01, ***p < 0.0001. Source data are provided as a Source Data ﬁle. ADC–astrocytic
differentiation condition, NDC–neuronal differentiation condition, ODC–oligodendrocytic differentiation condition. VZ–ventricular zone, LV–lateral ventricle
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Overall, our results indicate that Cic regulates NSC prolifera-
tion and cell fate in neurodevelopment and ODG, and that the
pro-proliferative and pro-OPC phenotypes observed with Cic loss
are largely mediated through Ets transcriptional de-repression.
Discussion
Genomic analyses of brain cancers have implicated CIC as a tumor
suppressor gene in diffuse gliomas, particularly ODGs3,4,36.
Here, we report for the ﬁrst time cell type-speciﬁc differences in
CIC expression in the brain. Moreover, our work provides new
insight into the roles of this putative tumor suppressor in reg-
ulating the developmental fate of neural stem/progenitor cells.
We found that Cic loss biases neural stem cells away from
selection of the neuronal lineage towards to selection of
glial lineages. Adding to prior knowledge that RAS/MAPK
pathway signaling and ETV5 are both involved in gliogenic
competence17,34, our results ﬁrmly place Cic at the intersection of
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two, providing a missing link between extrinsic differentiation
signals and the execution of transcriptional programs critical for
normal neuro- and gliogenesis. With respect to Cic and the anti-
neuronal bias that we observed, recent work by Lu et al.14 found
that disrupting Ataxin1-Cic complexes resulted in abnormal
maturation and maintenance of upper-layer cortical neurons—
with effects on behavior, learning, and memory. Though our
studies focused on early lineage selection events, and did not
systematically address questions of cell maturation, some of our
in vitro morphological ﬁndings are consistent with neuronal and
oligodendrocyte maturation defects being part of the Cic phe-
notype. Future work would be needed to deﬁne the complex
cellular dependencies on Cic, not only in the forebrain but also in
the cerebellum where Cic pathology has also been implicated37,38.
Our ﬁndings build on observations by Yang et al.13 that Cic
deﬁciency increases a population of proliferating OPCs in the
brain. We now provide mechanistic foundations for those
observations—identifying symmetric cell division alterations,
lineage selection effects, and a downstream effector. These pro-
vide tangible links between CIC loss and ODG biology—as both
dysregulated proliferation and the persistence of an immature
OPC phenotype are cardinal features of this cancer. Many par-
allels exist between normal OPCs and the cells comprising
ODG. In common, both OPCs and ODGs express PDGF,
PDGFR, and NG2, which control OPC differentiation39,40.
Together, the results may explain some of these ODG features,
and are consistent with other reports, suggesting that dysregula-
tion of OPCs or OPC-like cells are amongst the early changes in
gliomagenesis2,41. There are some notable differences between
the work by Yang et al.13, however, and our studies. One differ-
ence is that the prior study used HOG cells that, despite their
historic name, do not carry the ODG-deﬁning genetic features of
1p19q loss or CIC mutation. Similarly, the Pdgfra-ampliﬁed/
overexpressed mouse glioma model that was used is more akin to
an RTK-driven GBM than ODG. In deploying the BT88 and
BT54 models (which genetically and phenotypically recapitulate
ODG), our work may be closer to clinical relevance for ODG.
Another difference is that our studies also further clarify the
early neuronal-glial fate decision effects of NSCs, with the bias
away from neuronal fates and toward glial fates in the setting of
CIC loss. Most importantly, however, we now identify Ets de-
repression as a key mechanism underlying the phenotypic effects
of Cic loss in NSCs.
The observation that DNETV5 could abrogate so much of the
pro-proliferative and pro-OPC phenotype resulting from Cic loss
was unexpected, and together with our expression and ETV5
knockdown experiments, points to a critical role for this parti-
cular Ets factor. However, we do not exclude that other Ets factors
such as Etv4 may contribute. The dominant-negative construct
may not be entirely speciﬁc for Etv5; cross-reactivity has been
reported with similar approaches, and further experiments
would be required to dissect the relative contribution of different
Ets genes. Nevertheless, the identiﬁcation of Ets factors as
likely mediators is salient to the development of future therapies.
Reports of Ets inhibition through peptidomimetic or small
molecule approaches42–44 lend hope that Etv5 could potentially
be inhibited for clinical beneﬁt for ODG.
Finally, though relevant to ODG, our studies do not directly
model ODG. Our Cic conditional knockout mice, however, will
be a useful tool for future cell type- and stage-speciﬁc Cic deletion
in the context of other mutations such as of IDH1(R132H)45. We
conceptualize IDH1/2 mutations as a ﬁrst event in ODG, causing
epigenetic changes that expand the potential pool of cells vul-
nerable to transformation, with second-hit loss of CIC serving to
dysregulate proliferation, bias cells to oligodendroglial lineage,
and delay them in an immature state. Additional studies using
mouse models and human ODG samples, however, are needed
to further dissect the relationship between CIC and IDH muta-
tions. Although one recent study used single-cell RNA-Seq to
examine ODG cell subpopulations and did not detect any dif-
ferences between ODG cells with and without CIC mutation aside
from the increased expression of PEA3 Ets factors, the number
of cells analyzed was limiting for resolution of cell type-speciﬁc
differences, and functional studies had not been performed46.
Similar approaches with larger cell numbers might provide fur-
ther insight into the ODG biology with respect to CIC.
In summary, we show that Cic regulates proliferation, fate
decisions, and differentiation in neural stem cells, with loss
particularly expanding the OPC population. Furthermore, our
ﬁndings indicate that disruption of the Cic-Etv axis is central
to the biology of ODG.
Methods
Mice. CD1 outbred mice (Jackson Labs) were used for Cic expression analyses.
Cic conditional knockout (Cic-CKO) mice were generated at Taconic Artemis by
homologous recombination to ﬂank Cic exons 2–11 with loxP sites. The exons
targeted are 2–11 of Cic short form, transcript variant 1, NM_027882.4 (equivalent
to exons 3–12 of the Cic long form, NM_001302811.1, Cic transcript variant 4).
The targeting vector was generated using clones from the C57BL/6 J RPCIB-731
BAC library, and consisted of a 4.0 kb 5′ ﬂanking arm, neomycin resistance cassette
(ﬂanked by FRT sites), 5.5 kb loxP-ﬂanked region, a puromycin resistance cassette
(ﬂanked by F3 sites), and 6.0 kb 3′ ﬂanking arm. After homologous recombination
in C57BL/6 N Tac ES cells, generation of chimeric animals, and germline trans-
mission, NeoR and PuroR cassettes were removed via Flp recombination by
breeding with a Flp deleter line. The ﬁnal CIC-CKO allele carries loxP sites in
introns 1 and 11, and single residual FRT and F3 sites. Expression of Cre
recombinase results in deletion of exons 2–11 and frameshifting of the remaining
CIC-S exons 12–20. Genotyping primers were as follows: CIC 5′ ﬂanking region
(192 bp wt, 348 bp CKO allele) 5′-AGGAGGTTGTTACTCGCTATGG-3′ (for-
ward) and 5′-CTGATGTCCTAAGACCTTTACAAGG-3′ (reverse); CIC 3′ ﬂank-
ing region (273 bp wt, 410 bp CKO) 5′-CTTTGTCACTGTCTGCCTTCC-3′
(forward) and 5′-TGGGTAATACCACCGTGCC-3 (reverse)’. FoxG1-cre mice
(Jackson Labs) were bred to Cic-CKO mice to generate telencephalic CIC
Fig. 9 ODG cells require CIC loss or elevated ETV5 to maintain proliferation and stemness. a, c EdU incorporation in BT88 and BT54 ODG cell lines stably
transfected with control plasmid or with dominant-negative ETV5 (DNETV5). Representative images from BT88 cells a and quantitation of both BT88 and
BT54 c from n= 3 biologic replicates each. Statistical analyses performed by t test. b, d, e Neurosphere assays on BT88 and BT54 stably transfected with
control plasmid or with DNETV5. Representative images showing effect of DNETV5 on sphere formation in BT88 ODG cells b, with quantitation of sphere
number d and size e in both BT54 and BT88 ODG cells without and with DNETV5 after plating equal numbers of cells; data represent n= 3 biologic
replicates. Statistical analyses performed by t test. f CIC re-expression in BT88 cells decreases proliferation, sphere number, and sphere size; data
represent n= 3 biologic replicates. Statistical analyses performed by t test. g, h Lineage-speciﬁc differentiation capacity of BT88 ODG cells stably
transfected with either control plasmid, DNETV5, or CIC from n= 7 biologic replicates. After 10-day exposure to neuronal differentiation condition (NDC),
astrocyte differentiation condition (ADC), or oligodendrocyte differentiation condition (ODC), cells were analyzed for expression of Tuj1, GFAP, OLIG2, and
CNPase by immunoﬂuorescence g. Cell types were quantiﬁed as a percentage of total cell as indicated by DAPI nuclear counterstain h. Data from n≥ 3
biologic replicates. Statistical analyses by ANOVA with Tukey’s post hoc test. Data shown as mean ± SD. Source data are provided as a Source Data ﬁle.
All scale bars: 50 μm. ns–not signiﬁcant, *p < 0.05, **p < 0.01, ****p < 0.0001. NDC–neuronal differentiation condition, ADC–astrocytic differentiation
condition, ODC–oligodendrocytic differentiation condition
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Fig. 10 Tumorigenicity of ODG cells is reduced by CIC re-expression or ETV5 blockade. a, b Bioluminescence imaging of NOD-SCID mice at 6 weeks post-
orthotopic implantation of BT88 oligodendroglioma cells stably transfected with empty-GFP-luciferase or CIC-GFP-luciferase. Representative images a and
luminescence data b from ﬁve mice per cohort. Data shown as mean ± SD. Statistical analyses by student’s t test. **p < 0.01. c, e Representative images of
brain sections from mice implanted with control-GFP-luciferase BT88 cells or CIC-GFP-luciferase BT88 cells stained with H&E c or GFP e at 6 weeks post
implant. Scale bars: 50 μm. d, f Representative images of brain sections from mice implanted with control-GFP-luciferase BT88 cells or DNETV5-GFP
stained with H&E d or GFP f at 6 weeks post implant. Scale bars: 50 μm. g Kaplan–Meier survival analysis of mice implanted with BT88 cell transfected with
empty-GFP-luciferase or CIC-GFP-luciferase. n= 5 mice per cohort. Statistical analysis by log-rank (Mantel–Cox) test; p= 0.0021. h Kaplan–Meier survival
analysis for BT88 cell transfected with empty-GFP or DNETV5-GFP. n= 5 mice per cohort. Source data are provided as a Source Data ﬁle. Statistical
analysis by log-rank (Mantel–Cox) test; p= 0.0018
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knockouts and littermate controls. After killing, dissected brains were processed for
histology, western blotting, or cell culture. Knockout in tissue or cells post-cre was
conﬁrmed by Q-RT–PCR using primer/probe sets for CIC (Applied Biosystems)
and by Western blotting with anti-Cic. In all mouse experiments, the morning of
vaginal plug was designated embryonic day 0.5 (E0.5). Both males and females
were used.
In utero electroporation. In utero electroporation was performed as described
previously using the following plasmids: pLKO.1-Cic shRNA (Sigma,
TRCN0000304642; 5′-CCGGAGCGGGAGAAGGACCATATTCCTCGAGGAA-
TATGGTCCTTCTCCCGCTTTTTTG-3′), pLKO.1-non-targeting shRNA (Sigma;
5′-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCT-
TAGG-3′), pCIG2-Cre (which contains Cre-IRES-GFP), pCIC-ETV5 (which
contains Etv5-IRES-mCherry), Super piggyBac Transposase (Systems Biosciences,
SBI), and piggyBac cargo vector PB513B-1 (SBI) into which cDNAs were cloned
for Turbo-Cre and Etv5. The DNETV5 consists of an Etv5-EnR fusion (gift of
Dr. Carol Schuurmans) cloned into the piggyBac construct modiﬁed to contain the
CAG promoter and GFP-luciferase. DNA was prepared with Endo-free DNA kit
(Qiagen) and was injected at 1.5 μg/μl into the telencephalic vesicles of embryos
in time-staged pregnant females using a Femtojet 4i microinjector (Eppendorf)
then followed by electrical pulses (6 × 43 V, 950 ms interval) applied by platinum
tweezer-style electrodes (7 mm, Protech) uSsing a BTX square wave generator
(Harvard Apparatus). Post-procedure, embryos were allowed to develop until the
time of harvesting. EdU (50 mg/ml in phosphate-buffered saline; PBS) was injected
intraperitoneally into the pregnant dam 30 min prior to killing.
Neural stem cell culture. The VZ of E15 brains were dissected, and tissue was
dissociated to single cells using Accumax (EMD Millipore). Cells were grown at
37 °C, 5% CO2 in low-adhesion tissue culture ﬂasks (Sarstedt) in mouse neural
stem cell (mNSC) media consisting of NeuroCult Proliferation media (Stem Cell
Technologies) supplemented with heparin, epidermal growth factor (EGF 20 ng/
mL; Peprotech), and ﬁbroblast growth factor (FGF 20 ng/mL; Peprotech). When
spheres reached 100–200 µm in diameter, cells were split using Accumax and re-
plated at 20,000 cells/mL.
Transfection of cultured cells. In all, 1–4 × 106 dissociated cells were re-
suspended in 100 μL of Amaxa Mouse NSC Nucleofector Solution (VPG-1004,
Lonza) with 5 μg of plasmid DNA. Nucleofection was performed with a Nucleo-
fector II Device (Amaxa) using the A-033 program. Cells were returned to mouse
neural stem cell media for further expansion/selection. For siRNA-mediated
Etv5 knockdown, cells were transfected with 50 nM Etv5 or Etv4 ON-TARGET
Plus SMARTpool siRNAs (Dharmacon) using Lipofectamine 3000 reagent per
manufacturer’s protocol. Cells were assayed 48 h hours post transfection.
Trypan assay. In total, 150,000 cells were seeded per T25 ﬂask in mNSC media
and counted after 72 h on a TC20 cell counter (Biorad) using Trypan blue stain
(Thermo). Both dead and live cells were counted.
Paired cell assay. Dissociated cells were plated at 1000 cells/ml in mNSC media
on dishes coated with CTS CELLstart (Thermo). After 20 h, cells were ﬁxed in 4%
paraformaldehyde (PFA) and immunostained for Ki67. Pairs were scored as
symmetric proliferative if both daughter nuclei were Ki67+ , symmetric differ-
entiative if both were Ki67−, and asymmetric if one nucleus was Ki67+ and the
other Ki67−.
Neural colony-forming cell assay. Cells in semi-solid media were prepared using
the Neurocult NCFC Assay Kit (Stem Cell Technologies) per manufacturer’s
protocol. Cells were plated at a density of 1650 cells/ml using 1.5 ml per 35 mm
culture dish. Dishes were replenished after 7 days with 60 µl of neural stem cell
proliferation media supplemented with heparin, EGF, and FGF. Sphere number
and size were scored using a gridded scoring dish (Stem Cell Technologies). Eight-
cell aggregates were used as the cutoff for scoring.
Lineage-directed differentiation of NSCs. To promote neuronal differentiation,
NSCs were seeded in mNSC proliferation media (Stem Cell Technologies) on
coverslips coated with Poly-L-Ornitihine and Laminin. After 24 h, media was
replaced with Neurobasal Media, 2% B-27, 2 mM GlutaMAX-I (Thermo). After
4 more days dibutyryl cAMP (Sigma) was added daily to a ﬁnal concentration
of 0.5 mM. To promote oligodendroglial differentiation, NSCs were seeded on
coverslips coated with Poly-L-Ornitihine and Laminin. After 24 h, media was
replaced with Neurobasal media, 2% B-27, GlutaMAX-I, 30 ng/mL 3,3′,5-Tri-iodo-
L-thyronine sodium (Sigma). To promote astrocyte differentiation, NSCs were
seeded on coverslips coated with Geltrex (Thermo). After 24 h, media was replaced
with DMEM, 1% N2-Supplement, 2 mM GlutaMAX-I, 1% FBS. The cells were
maintained in the respective differentiation media for 10 days prior to assays
of lineage and differentiation.
Immunostaining. Tissue was ﬁxed overnight in 4% PFA, cryoprotected in 30%
sucrose/PBS, and embedded in Tissue-Tek O.C.T. (Sakura Finetek) prior to cutting
6 μm cryosections on Superfrost Plus slides (VWR). Cultured cells grown on
coverslips were ﬁxed for 20 min in 4% PFA then rinsed in PBS. Permeabilization
was performed with 1 × TBST (Tris-buffered saline: 25 mM Tris, 0.14 M NaCl, 0.1%
Triton X-100) for 15 min at room temperature (RT). Three percent% goat or horse
serum in TBST × 30 min was used for block. Primary antibodies applied for 1 h at
RT or O/N at 4 °C in block. Alexa Fluor secondary antibodies were applied at 1:500
dilution for 1 h RT. Nuclei were counterstained in 4′,6-diamidino-2-phenylindole
(DAPI; Santa Cruz) and mounted with FluorSave Reagent (Calbiochem). For
immunostaining of tissue sections when two or more primary antibodies were from
the same host species and for comparison of cell type speciﬁc CIC expression,
the Opal 4-color IHC kit (Perkin Elmer) was used per manufacturer’s protocol.
Western blotting. Cells/tissue was lysed in RIPA buffer (10 mM Tris-Cl pH 8,
1 mM ethylenediaminetetraacetic acid, 1% Triton X-100, 0.1% sodium deox-
ycholate, 0.1% sodium dodecyl sulphate, 140 mM NaCl, 1 mM phenylmethylsulfonyl
ﬂuoride) with 1 × Halt Protease and Phosphatase Inhibitor Cocktail (Thermo). In
total, 20 μg protein lysate (50 μg in the case of CIC probing) was run on 4–12% Bis-
Tris or 3–8% Tris-Acetate gels (Thermo). Protein was transferred to polyvinylidene
diﬂuoride membranes in NuPAGE Transfer Buffer (Thermo). Membranes were
blocked in TBST with 5% powdered milk. Primary antibodies diluted were applied
for 1 h at room temperature or overnight at 4 °C. Horseradish peroxidase-coupled
secondary antibodies were applied for 1 h at room temperature. Membranes were
developed using ECL Plus Western Blotting Reagent (GE Healthcare) and X-
ray ﬁlm.
Antibodies. Primary antibodies directed against the following were used: CIC
(Rabbit Polyclonal, 1:500 IF, 1:1000 WB; A301-204, Bethyl), CIC (Rabbit Poly-
clonal, 1:100 IF; PA1-46018; Thermo), Olig2 (Mouse Monoclonal, 1:250 IF, 1:1000
WB, MABN50, clone 211F1, Millipore), Olig2 (Rabbit Polyclonal, 1:500, AB9610,
Millipore), ETV1 (Mouse Monoclonal, 1:1000 WB, SAB1403794, clone 4C12,
Sigma), ETV4 (Rabbit Polyclonal, 1:2000 WB, LS-C98380, LS BioSciences), ETV4
(Rabbit Polyclonal, 1:500 IF 1:2000 WB, ARP32263_P050, AVIVA Systems
Biology), ETV5 (Rabbit Polyclonal, 1:1000 WB; sc-22807, Santa Cruz), ETV5
(Polyclonal Rabbit, 1:500 IF, 1:2000 WB, 13011-1-AP, ProteinTech), GFP (Rabbit
Polyclonal, 1:500 IF; A11122, Thermo), GFP (Mouse Monoclonal, 1:250 AF,
ab38689, clone 6AT316, Abcam), SOX2 (Rabbit Monoclonal, 1:500 IF, ab92494,
clone EPR3131, Abcam), Turbo-GFP (Mouse Monoclonal, 1:500 IF, TA150041,
clone OTI2H8, Origene), SOX2 (Rabbit Monoclonal, 1:500 IF, 1:1000 WB, #3728,
clone C70B1, Cell Signalling), SOX9 (1:500 IF, ab76997, clone 3C10, Abcam),
SOX9 (Rabbit Polyclonal, 1:250 IF,1:1000 WB, AB5535, Millipore), PDGFRA
(Rabbit Monoclonal, 1:500 IF, 1:1000 WB, 3174 S(D1E1E), Cell Signalling),
PDGFRA (Goat, Polyclonal, 1:250 IF, AF1062, R&D), CC1 (1:500 IF, APC (Ab-7)
(OP80, clone CC1, Millipore), MBP (1:500 IF, ab40390, Abcam), Nestin (1:500 IF,
1:1000 WB, MAB353, Millipore), Tbr1 (1:500 IF, AB2261, Millipore), Tbr2 (Mouse
Monoclonal, 1:500 IF, AB15894, Millipore), Neuron-speciﬁc beta-III Tubulin
(Mouse Monoclonal, 1:500 IF, 1:1000 WB, MAB1195, clone Tuj1, R&D), GFAP
(Mouse Monoclonal, 1:800 IF, 1:1000 WB, MAB360, clone GA5, Millipore), GFAP
(Rat Monoclonal, 1:500 IF, 345860, clone 2.2B10, Millipore), ALDH1 (Rabbit
Polyclonal, 1:250 IF, ab87117, Abcam), NeuN (Mouse Monoclonal, 1:500 IF,
MAB377, clone A60, Millipore), Cre (Rabbit Polyclonal, 1:500 IF, 1:2000 WB,
NB100-5613, Novus), Ki67 (Rabbit Polyclonal, 1:200; ab15580, Abcam), EdU
(61135-33-9, Carbosynth US LLC). For routine immunoﬂuorescence, secondary
antibodies were: Alexa Fluor-488, -594 and -633) conjugated species-speciﬁc
antibodies (Thermo) were used at 1:500 dilution. For the OPAL method (OPAL
4-color kit, Perkin Elmer), secondary antibodies used were anti-mouse HRP
polymer (DAKO) and anti-rabbit HRP polymer (DAKO).
Transcriptional analysis. Total RNA was extracted using AllPrep DNA/RNA/
Protein Mini Kit (Qiagen) per manufacturer’s protocol. For each of three biologic
replicates per condition, 100 ng RNA was subjected to nanoString analysis on
nCounter system (NanoString Technologies) using a custom gene expression
codeset containing neurodevelopmental and brain cancer associated genes, and
three housekeeping genes. Data were analyzed using nSolver software and exported
to PRISM software for further statistical analyses. Counts for Etv1, Etv4, and Etv5
were normalized to the average of three housekeeping genes (GAPDH, Actin,
Tubulin beta chain).
In situ hybridization (ISH). Digoxygenin (DIG)-labeled riboprobes were prepared
using a 10 × DIG-labeling kit (Roche), and ISH was performed as described
previously using probes for GFP and Etv517.
Chromatin immunoprecipitation. In total, 50 mg P6 mouse forebrain tissue was
use per chromatin immunoprecipitation (ChIP) assay. ChIP was performed with
the SimpleChip Plus Kit with magnetic beads (Cell Signalling) per manufacturer’s
protocol with the following exceptions. Tissue was disaggregated using a Dounce
homogenizer. In place of micrococcal nuclease, shearing was performed on a UCD
Bioruptor on high power with intervals of 30 s on, 1 min off for 30 min. A total of
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1.5 µl of anti-CIC (PA1-46018, Thermo) was used per immunoprecipitation
reaction. Histone H3 antibody and normal rabbit IgG were used as positive and
negative controls, as supplied in the kit. PCR primers for the ETV5 promoter
region were: 5′-GGTGCAGGCCGAGGCCAGGG-3′ (For) and 5′-CATTGACCA
ATCAGCACCGG-3′ (Rev).
Image analysis. Coronal sections at the level of the anterior commissure were used
in all quantitations of cell populations and staining intensities in the dorsal cerebral
cortex and corpus callosum. Slides were imaged on AxioObserver ﬂuorescence
microscope (Zeiss). Images were processed using CS6 Photoshop software (Adobe)
for orientation, false colorization, and overlay/colocalization. Enumeration of cells
positive for cytoskeletal, cytoplasmic or membrane proteins was performed
manually by counting positive cells using the Photoshop CS6 counting tool.
Quantitation of CIC nuclear staining intensity and MBP staining density was
performed using FIJI software47 as follows. Images were ﬁrst processed using
Gaussian blur, then background subtracted. Default threshold limits were used in
the threshold tool. Images were converted to binary and watershed was run to
separate clumped cells. Nuclear staining was quantitated by using the analyzing
particles option with separate cutoffs set for each antibody used. For quantitation
of MBP expression on tissue sections, FIJI was used by drawing regions of interest
on the lateral corpus callosum (cingulum), and the mean integrated density in the
regions of interest was calculated.
Intracranial xenografts and bioluminescence imaging. BT88 ODG cells35 were
obtained from the Dr. S. Weiss, University of Calgary. A total of 1 × 105 BT88 cells
stably transfected with CIC-GFP-Luciferase or DNETV5-GFP or respective empty
vectors were stereotactically implanted into the right striata of 6- to 8-week-old
NOD/SCID mice. Six weeks post implantation, tumor burden was measured either
by bioluminescence imaging using IVIS Spectrum In Vivo Imaging System
(Xenogen) and/or by histology from killed animals. Mice were anaesthetized under
isoﬂurane and intraperitoneal injection of XenoLight D-Luciferin (Perkin Elmer)
was administered at a dose of 150 mg/kg body weight. Acquisition of biolumi-
nescence images was performed 10 min post injection. Analysis was performed
using Living Image Software by measurement of photon counts (photon/s/cm2)
with a region of interest drawn around the bioluminescence signal.
Statistics. Data are represented as mean ± SD from at least three biologic replicates
for experiments. Comparisons between experimental and control samples were
made using two-tailed t test or, when there were more than two groups, using
ANOVA. Tukey’s procedure was applied post hoc to correct for multiple com-
parisons during multiple pairwise analyses (e.g., differential Cic expression among
cell types). Bonferroni post hoc correction was applied for statistical analysis
of data from NanoString assays. Survival curves were analyzed by log-rank
(Mantel–Cox) test. Statistical analyses were performed using Prism software
(Graphpad).
Study approval. Animal use was approved by the University of Calgary Animal
Care Committee (protocol AC16-0266) in compliance with the Guidelines of the
Canadian Council of Animal Care. Collection and generation of the glioma cell
lines was approved by the Health Research Ethics Board of Alberta (protocols
HREBA.CC-16-0762 and HREBBA.CC-16-0154).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its Supplementary Information ﬁles. All biological materials used in this
study are available from the corresponding author upon reasonable request.
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